Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Treasury Shares: 2016

  • Northwest Biotherapeutics' Treasury Shares was N/A to $8,052 in Q4 2016 from the same period last year, while for Dec 2016 it was $8,052, marking a year-over-year change of. This contributed to the annual value of $8,052 for FY2016, which is N/A change from last year.
  • As of Q4 2016, Northwest Biotherapeutics' Treasury Shares stood at $8,052, which was down 99.90% from $8.1 million recorded in Q3 2016.
  • Over the past 5 years, Northwest Biotherapeutics' Treasury Shares peaked at $8.1 million during Q3 2016, and registered a low of $8,052 during Q4 2016.
  • Over the past 1 years, Northwest Biotherapeutics' median Treasury Shares value was $4.0 million (recorded in 2016), while the average stood at $4.0 million.